Literature DB >> 8406791

Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii.

C A Hunter1, J S Abrams, M H Beaman, J S Remington.   

Abstract

Levels of cytokine mRNA were studied in the central nervous system (CNS) of SCID mice infected with Toxoplasma gondii. This infection led to 100% mortality by day 23 postinfection. Inflammation was observed in the lungs on day 7 and in the heart, liver, and kidneys on days 14 and 18 of infection. In the CNS, necrotic, acellular lesions that contained numerous parasites, accompanied by a localized astrocyte activation, were evident on day 14. Polymerase chain reaction-assisted amplification of RNA revealed that, although transcripts for interleukin-1 alpha (IL-1 alpha) and IL-1 beta were present in the brains of uninfected mice, increased levels of these transcripts were detected on day 7 of infection. Transcripts for macrophage inflammatory protein 1 and transforming growth factor beta were also detected in brains of infected mice at this time point. On days 14 and 18, levels of these transcripts had increased and transcripts for IL-6, IL-10, gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), and granulocyte-macrophage colony-stimulating factor (GM-CSF) were also detected. Transcripts for IL-2 or IL-4 were not detected at any of the time points. Detection of locally produced cytokine transcripts may reflect involvement of the cytokines in the immunopathogenesis of this infection or involvement in mediating antitoxoplasma activity. To assess the possible role of endogenous IFN-gamma, TNF-alpha, IL-10, IL-6, and GM-CSF, cytokine-neutralizing monoclonal antibodies were administered to infected SCID mice. Neutralization of IFN-gamma or TNF-alpha led to earlier mortality than that in controls. In contrast, treatment with antibody to IL-10 and IL-6 increased survival time. Treatment with anti-GM-CSF did not alter the time to death. These results indicate that TNF-alpha and IFN-gamma are both involved in T-cell-independent mechanisms of resistance to T. gondii in SCID mice and that IL-10 and IL-6 may downregulate the immune response to this pathogen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406791      PMCID: PMC281121          DOI: 10.1128/iai.61.10.4038-4044.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.

Authors:  R T Gazzinelli; F T Hakim; S Hieny; G M Shearer; A Sher
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 3.  AIDS commentary. Toxoplasmic encephalitis.

Authors:  B J Luft; J S Remington
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

4.  Immunohistological study of the anatomic relationship of toxoplasma antigens to the inflammatory response in the brains of mice chronically infected with Toxoplasma gondii.

Authors:  F K Conley; K A Jenkins
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

5.  Inhibition of growth of Toxoplasma gondii in cultured fibroblasts by human recombinant gamma interferon.

Authors:  E R Pfefferkorn; P M Guyre
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

6.  Activation of murine macrophages and a bovine monocyte cell line by bovine lymphokines to kill the intracellular pathogens Eimeria bovis and Toxoplasma gondii.

Authors:  H P Hughes; C A Speer; J E Kyle; J P Dubey
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

7.  Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

Authors:  A Fontana; H Hengartner; N de Tribolet; E Weber
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

8.  Interleukin 1 of the central nervous system is produced by ameboid microglia.

Authors:  D Giulian; T J Baker; L C Shih; L B Lachman
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

9.  Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.

Authors:  P P Nawroth; I Bank; D Handley; J Cassimeris; L Chess; D Stern
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

10.  Activation of human macrophages. Comparison of other cytokines with interferon-gamma.

Authors:  C F Nathan; T J Prendergast; M E Wiebe; E R Stanley; E Platzer; H G Remold; K Welte; B Y Rubin; H W Murray
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  33 in total

1.  Changes in cytokine levels during reactivation of Toxoplasma gondii infection in lungs.

Authors:  G A Filice; C R Clabots; P E Riciputi; O Goñi-Laguardia; C Pomeroy
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon.

Authors:  C A Hunter; T Slifer; F Araujo
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.

Authors:  J Brieland; D Essig; C Jackson; D Frank; D Loebenberg; F Menzel; B Arnold; B DiDomenico; R Hare
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  IL-1R Regulates Disease Tolerance and Cachexia in Toxoplasma gondii Infection.

Authors:  Stephanie J Melchor; Claire M Saunders; Imani Sanders; Jessica A Hatter; Kari A Byrnes; Sheryl Coutermarsh-Ott; Sarah E Ewald
Journal:  J Immunol       Date:  2020-04-29       Impact factor: 5.422

5.  Astrocytic TGF-β signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection.

Authors:  Egle Cekanaviciute; Hans K Dietrich; Robert C Axtell; Aaron M Williams; Riann Egusquiza; Karen M Wai; Anita A Koshy; Marion S Buckwalter
Journal:  J Immunol       Date:  2014-05-23       Impact factor: 5.422

6.  Toxoplasma gondii induces B7-2 expression through activation of JNK signal transduction.

Authors:  Pedro Morgado; Yi-Ching Ong; John C Boothroyd; Melissa B Lodoen
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

7.  Contribution of interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 ligand pathways to the development of a pathological T-cell response in IL-10-deficient mice.

Authors:  Ulrike Wille; Eric N Villegas; Linden Craig; Robert Peach; Christopher A Hunter
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

8.  Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice.

Authors:  Y Suzuki; S Rani; O Liesenfeld; T Kojima; S Lim; T A Nguyen; S A Dalrymple; R Murray; J S Remington
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

9.  Studies on the role of interleukin-12 in acute murine toxoplasmosis.

Authors:  C A Hunter; E Candolfi; C Subauste; V Van Cleave; J S Remington
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

10.  Interleukin-10 and pathogenesis of murine ocular toxoplasmosis.

Authors:  Fangli Lu; Shiguang Huang; Lloyd H Kasper
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.